Status: Recruiting
Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination
The goal of this observational study is to learn about the immunity induced by the Qdenga® vaccine in vaccinees. Participants that will receive the Dengue vaccine as part of their routine before a travel will be asked to undergo a blood sample at the time of administration of the first dose (T0), 24-48 hours after the first dose (T1) of the vaccine, immediately before the second dose (T2 ) and one to two months after the second dose (T3). Possibly a further sample will be collected within 2 years.
Participants needed: 402
Trial details
Age: 4+Biological sex: AllType: ObservationalSponsor: IRCCS Sacro Cuore Don Calabria di NegrarUpdated: May 18, 2025Locations: 1
Eligibility criteria
Subjects of both sexes presenting to the DITM to receive the anti-DENV vaccine w... [+2]
Age < 4 years. [+1]